IRIS
DIOTALLEVI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.960
EU - Europa 815
AS - Asia 503
SA - Sud America 122
AF - Africa 74
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.481
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.943
SG - Singapore 183
RU - Federazione Russa 178
IT - Italia 163
CN - Cina 151
SE - Svezia 135
IE - Irlanda 132
BR - Brasile 112
HK - Hong Kong 108
CI - Costa d'Avorio 41
FR - Francia 38
GB - Regno Unito 37
UA - Ucraina 34
DE - Germania 30
IN - India 27
MA - Marocco 24
FI - Finlandia 17
BE - Belgio 10
AT - Austria 9
CA - Canada 8
GR - Grecia 8
IQ - Iraq 8
NL - Olanda 7
DK - Danimarca 6
AU - Australia 5
CZ - Repubblica Ceca 5
JP - Giappone 5
CU - Cuba 4
KR - Corea 4
BD - Bangladesh 3
ES - Italia 3
MX - Messico 3
TR - Turchia 3
ZA - Sudafrica 3
AR - Argentina 2
CH - Svizzera 2
CO - Colombia 2
EG - Egitto 2
KE - Kenya 2
NI - Nicaragua 2
PH - Filippine 2
PY - Paraguay 2
AM - Armenia 1
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
EU - Europa 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
LB - Libano 1
NO - Norvegia 1
PE - Perù 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
VN - Vietnam 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.481
Salva come PNG Salva come JPEG
Città #
Chandler 385
Des Moines 248
Ashburn 147
Dublin 125
Boardman 119
Hong Kong 107
New York 107
Singapore 95
Fairfield 88
The Dalles 60
Jacksonville 56
Lawrence 46
Princeton 46
Woodbridge 45
Moscow 42
Abidjan 40
Wilmington 40
Seattle 35
Cambridge 27
San Mateo 27
Houston 26
Los Angeles 22
Centro 21
Guangzhou 20
Pune 20
Ann Arbor 18
Turin 18
Ancona 17
London 17
San Diego 17
Washington 16
Helsinki 11
Redmond 11
Brussels 10
Dallas 10
Boydton 9
Shanghai 9
Beijing 7
Rome 7
Wuhan 7
Cagliari 6
Norwalk 6
Toronto 6
Nuremberg 5
Rio de Janeiro 5
Santa Clara 5
São Paulo 5
Civitanova Marche 4
Havana 4
Najaf 4
Naples 4
Olomouc 4
Polverigi 4
San Vito Chietino 4
Turku 4
Vienna 4
Brooklyn 3
Clifton 3
Falerone 3
Frankfurt am Main 3
Gatchina 3
Hounslow 3
Johannesburg 3
Kingston 3
Nanjing 3
Porto Alegre 3
Shenzhen 3
Sydney 3
Tokyo 3
Wuxi 3
Allerød Municipality 2
Ascoli Piceno 2
Atlanta 2
Banhā 2
Basra 2
Belo Horizonte 2
Boston 2
Cascina 2
Castelfidardo 2
Catania 2
Cernusco sul Naviglio 2
Cuiabá 2
Curitiba 2
Florence 2
Ginosa 2
Guwahati 2
Hangzhou 2
Heze 2
Itajaí 2
Itaquaquecetuba 2
Jiaxing 2
Kensington 2
Kilburn 2
Melbourne 2
Milan 2
Nairobi 2
New Bedfont 2
New Delhi 2
Norrköping 2
Parma 2
Totale 2.354
Salva come PNG Salva come JPEG
Nome #
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 89
Mesenchymal stem cell profile in actinic keratosis and its modification after topical application of ingenol mebutate 89
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 89
miRNome analysis in psoriatic patients treated with anti IL- 23: a cohort study 83
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 83
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 80
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review 80
Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know 80
Buschke–ollendorff syndrome in a 6-year old patient: Clinical anhistopathological aspects of a rare disease 80
Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital 79
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 74
Granuloma faciale successfully treated with ingenol mebutate 73
Reticulated acanthoma with sebaceous differentiation 73
Safety update of etanercept treatment for moderate to severe plaque psoriasis 72
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study 69
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 69
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience 69
Novel therapeutic approaches and targets for treatment of chronic urticaria: New insights and promising targets for a challenging disease 68
The efficacy of in vivo administration of Apremilast on mesenchymal stem cells derived from psoriatic patients 67
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 66
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 66
Novel Therapeutic Approaches and Targets for Treatment of Psoriasis 65
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 65
Topical application of fumaric acid esters improves appearance of nail psoriasis 65
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 64
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 64
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 64
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities 64
Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience. 63
Skin involvement in patients with psoriatic arthritis: preliminary results of treatment with apremilast in real world setting. 63
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 59
Psoriasis as an immune-mediated and inflammatory systemic disease: From pathophysiology to novel therapeutic approaches 57
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 56
Acral Leukoderma: Is It Always Vitiligo? 55
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 54
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 53
Asymptomatic pigmentation of the skin in a child: babywipes, once again 53
Saliva proteomics as fluid signature of inflammatory and immune mediated skin diseases 52
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 49
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 48
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 48
Saliva and Oral Diseases 47
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 46
The role of the optical super high magnification dermoscopy (O.S.H.M.D) in the management of melanocytic lesions 45
A tricky case of contact dermatitis: Simultaneous allergic reaction to topical and oral acyclovir, and scar gel 44
How to fight SARS-COV-2 vaccine hesitancy in patients suffering from chronic and immune-mediated skin disease: four general rules 43
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 43
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art 40
Late Patch Test Reaction to Acrylates in 2 Patients: Should We Schedule a Check at Weeks 2 and 3? 40
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management 39
Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study 38
Infliximab-induced eruptive sebaceous hyperplasia in patient treated for ulcerative colitis: first reported case 38
Trichorhinophalangeal syndrome: a case report and brief literature review. 36
A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside 34
InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study 33
Role of Daptomycin in Cutaneous Wound Healing: A Narrative Review 29
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 28
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review 28
Biological treatments for pediatric psoriasis: state of the art and future perspectives 27
miRNAs, Mesenchymal Stromal Cells and Major Neoplastic and Inflammatory Skin Diseases: A Page Being Written: A Systematic Review 27
Role of daptomycin in cutaneous wound healing: a narrative review 23
Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature 23
Clinical-epidemiological aspects of the Monkeypox 2022 epidemic: A multicentre study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases 22
The pharmacological treatment and management of hyperhidrosis 20
Mesenchymal Stem Cells and Psoriasis: Systematic Review 20
Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study 19
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study 15
Pain Control during the Treatment of Primary Palmar Hyperhidrosis with Botulinum Toxin A by a Topical Application of Liposomal Lidocaine: Clinical Effectiveness 15
Totale 3.621
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.086
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 0 0 0 0 0 0 3 18
2020/2021287 14 21 24 17 22 2 9 19 29 27 73 30
2021/2022368 10 41 3 2 42 21 3 28 28 7 98 85
2022/20231.090 81 112 67 104 61 335 1 51 191 2 56 29
2023/2024650 88 11 59 59 81 179 13 55 4 24 23 54
2024/20251.128 152 119 35 42 83 51 128 63 252 89 114 0
Totale 3.621